Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Vera Therapeutics Q3 EPS $(0.91) Down From $(0.36) YoY

Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.91) per share. This is a 152.78 percent decrease over losses of $(0.36) per share from the same period last year.
byBenzinga Newsdesk
November 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.91) per share. This is a 152.78 percent decrease over losses of $(0.36) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Alcon: Q2 Earnings Insights

By Benzinga Insights
Today, 10:20 PM
  Alcon (NYSE:ALC) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Alcon beat estimated earnings by 28.57%, reporting an EPS of $0.63 versus an estimate of $0.49.

ALC